Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03134430
Other study ID # LFoquan
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 10, 2017
Est. completion date May 1, 2023

Study information

Verified date May 2018
Source The First Affiliated Hospital of Nanchang University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It has been reported local anesthetics could inhibit tumor cell proliferation, metastasis and invasion ability,but it is still lack of clinical evidence. Our study aims to explore the effects of regional nerve block on cancer recurrence and the mechanism.


Description:

1. To study the effects of TAP block under ultrasound guide on the recurrence of gastric carcinoma, colon cancer, rectal carcinoma and liver cancer and the underlying mechanisms.

2. To clarify the effects of Lateral thoracic nerve block under ultrasound guide on the recurrence of lung cancer and the underlying mechanisms.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400
Est. completion date May 1, 2023
Est. primary completion date March 25, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with primary cancer undergoing elective surgery under general anesthesia

Exclusion Criteria:

- Disagree to participate,drop out,lose track, infectious abdominal wall,abnormal puncture point,coagulation dysfunction,allergy of local anesthetic ,immune disease,cancer metastasis,mental disease, acute and chronic infectious disease or other severe disease.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Normal saline
Injection of Normal saline around peripheral nerve
peripheral Nerve block
Injection of local anesthetics around peripheral nerve

Locations

Country Name City State
China The first affiliated hospital of nanchang university Nanchang Jiangxi

Sponsors (1)

Lead Sponsor Collaborator
Luo Foquan

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the effect of nerve block on the cancer recurrence rate and survival rate postoperation to trace cancer recurrence after tumor resection with CT scaning and tumor biological maker test for 5 years up to 5 years after surgery
Secondary dosage of intraoperative anesthetic Record the propofol and remifentanil during the operation intraoperative period
Secondary the effect of nerve block on the percentage and classification of immunocyte and content of cytokines percentage and classification of immunocyte will be detected by Use flow cytometry, and cytokines will be detected by ELISA at 0h, 24h, 48h after nerve block
Secondary VAS after operation Assess the visual analogue scale 24,48h after nerve block at 24h, 48h after nerve block
Secondary activity after operation Observe recovery time of gastrointestinal function and off-bed activity after nerve block up to 2 weeks
Secondary Hospital stay Observe length of hospital stay up to 4 weeks after surgery
See also
  Status Clinical Trial Phase
Completed NCT02559323 - LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey
Completed NCT04778540 - Online Survey of Nutrition Status in Chinese Non-hospitalized Cancer Patients
Recruiting NCT05683652 - The Effect of Education and Telephone Follow-up Given to Cancer Patients Receiving Immunotherapy on Symptom Management and Self-care Power N/A
Completed NCT06280612 - The Effect of Live Cat and Simulation Cat Therapies on Oncology Patients N/A
Withdrawn NCT04469478 - Virtual Reality in Imaging Review for Cancer Patients N/A
Recruiting NCT05288244 - The Effect of Foot Bath and Lavender Oil Sniffing on the Severity of Insomnia in Cancer Patients N/A